D. Patey and W. Dyson, The Prognosis of Carcinoma of the Breast in Relation to the Type of Operation Performed, British Journal of Cancer, vol.2, issue.1, pp.7-13, 1948.
DOI : 10.1038/bjc.1948.2

V. Fourchotte and A. Fitoussi, Chirurgie d'ex??r??se totale du sein, 2011.
DOI : 10.1016/B978-2-294-06245-2.50003-6

D. Sarrazin, M. Lê, J. Rouëssé, G. Contesso, J. Petit et al., Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less the experience of the institut gustave-roussy, Cancer, vol.26, issue.5, pp.1209-1222, 1984.
DOI : 10.1159/000400884

U. Veronesi, R. Saccozzi, D. Vecchio, M. Banfi, A. Clemente et al., Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the Breast, New England Journal of Medicine, vol.305, issue.1, pp.6-11, 1981.
DOI : 10.1056/NEJM198107023050102

U. Veronesi, A. Banfi, B. Salvadori, A. Luini, R. Saccozzi et al., Breast conservation is the treatment of choice in small breast cancer: Long-term results of a randomized trial, European Journal of Cancer and Clinical Oncology, vol.26, issue.6, pp.668-70, 1990.
DOI : 10.1016/0277-5379(90)90113-8

B. Fisher, C. Redmond, R. Poisson, R. Margolese, N. Wolmark et al., Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer, New England Journal of Medicine, vol.320, issue.13, pp.822-830, 1989.
DOI : 10.1056/NEJM198903303201302

K. Straus, A. Lichter, M. Lippman, D. Danforth, S. Swain et al., Results of the National Cancer Institute early breast cancer trial, J Natl Cancer Inst Monogr, issue.11, pp.27-32, 1992.

J. Van-dongen, H. Bartelink, I. Fentiman, T. Lerut, F. Mignolet et al., Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial, J Natl Cancer Inst Monogr, issue.11, pp.15-23, 1992.

M. Blichert-toft, C. Rose, J. Andersen, M. Overgaard, C. Axelsson et al., Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group, J Natl Cancer Inst Monogr, issue.11, pp.19-25, 1992.

B. Fisher, S. Anderson, C. Redmond, N. Wolmark, D. Wickerham et al., Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer, New England Journal of Medicine, vol.333, issue.22, pp.1456-61, 1995.
DOI : 10.1056/NEJM199511303332203

J. Jacobson, D. Danforth, K. Cowan, T. Angelo, S. Steinberg et al., Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer, New England Journal of Medicine, vol.332, issue.14, pp.907-918, 1995.
DOI : 10.1056/NEJM199504063321402

J. Van-dongen, A. Voogd, I. Fentiman, C. Legrand, R. Sylvester et al., Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial, Journal of the National Cancer Institute, vol.92, issue.14, pp.1143-50, 2000.
DOI : 10.1093/jnci/92.14.1143

S. Scholl, A. Fourquet, B. Asselain, J. Pierga, J. Vilcoq et al., Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6, European Journal of Cancer, vol.30, issue.5, pp.645-52, 1994.
DOI : 10.1016/0959-8049(94)90537-1

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux et al., Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18., Journal of Clinical Oncology, vol.15, issue.7, pp.2483-93, 1997.
DOI : 10.1200/JCO.1997.15.7.2483

J. Hage, . Van-der, C. Velde, . Van-de, J. Julien et al., Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902, Journal of Clinical Oncology, vol.19, issue.22, pp.4224-4261, 2001.
DOI : 10.1200/JCO.2001.19.22.4224

L. Mauriac, G. Macgrogan, A. A. Durand, M. Floquet, A. Debled et al., Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up, Annals of Oncology, vol.10, issue.1, pp.47-52, 1999.
DOI : 10.1023/A:1008337009350

B. Fisher, J. Jeong, S. Anderson, J. Bryant, E. Fisher et al., Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation, New England Journal of Medicine, vol.347, issue.8, pp.567-75, 2002.
DOI : 10.1056/NEJMoa020128

U. Veronesi, N. Cascinelli, L. Mariani, M. Greco, R. Saccozzi et al., Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer, New England Journal of Medicine, vol.347, issue.16, pp.1227-1259, 2002.
DOI : 10.1056/NEJMoa020989

C. Early-breast, . Trialists-'collaborative, . Group, . Ebctcg-), C. Davies et al., Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials, Lancet Lond Engl. 27 août, vol.378, issue.9793, pp.771-84, 2011.

C. Davies, H. Pan, J. Godwin, R. Gray, R. Arriagada et al., Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial, The Lancet, vol.381, issue.9869, pp.805-821, 2013.
DOI : 10.1016/S0140-6736(12)61963-1

E. Winer, C. Hudis, H. Burstein, A. Wolff, K. Pritchard et al., American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor???Positive Breast Cancer: Status Report 2004, Journal of Clinical Oncology, vol.23, issue.3, pp.619-648, 2004.
DOI : 10.1200/JCO.2005.09.121

S. Goel, R. Sharma, A. Hamilton, and J. Beith, LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women, Cochrane Database Syst Rev, vol.14, issue.34, p.4562, 2009.
DOI : 10.3310/hta10340

D. Reid, J. Doughty, R. Eastell, S. Heys, A. Howell et al., Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group, Cancer Treatment Reviews, vol.34, issue.1, pp.3-18, 2008.
DOI : 10.1016/j.ctrv.2008.03.007

V. Semiglazov, J. Bavli, V. Moiseyenko, S. Rzhankov, N. Migmanova et al., Clinical trials on adjuvant chemotherapy for breast cancer, Cancer, vol.33, issue.10, pp.1957-60, 1986.
DOI : 10.1002/1097-0142(19860515)57:10<1957::AID-CNCR2820571012>3.0.CO;2-A

G. Viani, S. Afonso, E. Stefano, D. Fendi, L. Soares et al., Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials, BMC Cancer, vol.20, issue.suppl 1, p.153, 2007.
DOI : 10.1200/JCO.20.5.1215

X. Zhang, X. Zhang, T. Zhang, F. Yu, X. Wei et al., Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: a systematic review, Disponible sur, 2014.
DOI : 10.1002/ijc.28234

J. Rossari, O. Metzger-filho, M. Paesmans, K. Saini, A. Gennari et al., Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence, Journal of Oncology, vol.35, issue.1, p.417673, 2012.
DOI : 10.2165/11595910-000000000-00000

A. Paterson, S. Anderson, B. Lembersky, L. Fehrenbacher, C. Falkson et al., Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial, The Lancet Oncology, vol.13, issue.7, pp.734-776, 2012.
DOI : 10.1016/S1470-2045(12)70226-7

D. Santini, L. Stumbo, C. Spoto, D. Onofrio, L. Pantano et al., Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence, Breast Cancer Research, vol.26, issue.1, p.121, 2015.
DOI : 10.1093/annonc/mdu544

URL : https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0634-8?site=breast-cancer-research.biomedcentral.com

J. Berg, The significance of axillary node levels in the study of breast carcinoma, Cancer, vol.7, issue.4, pp.776-784, 1955.
DOI : 10.1002/1097-0142(1955)8:4<776::AID-CNCR2820080421>3.0.CO;2-B

A. Lucci, L. Mccall, P. Beitsch, P. Whitworth, D. Reintgen et al., Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011, Journal of Clinical Oncology, vol.25, issue.24, pp.3657-63, 2007.
DOI : 10.1200/JCO.2006.07.4062

R. Cabanas, An approach for the treatment of penile carcinoma, Cancer, vol.15, issue.2, pp.456-66, 1977.
DOI : 10.1148/79.2.209

D. Morton, D. Wen, J. Wong, J. Economou, L. Cagle et al., Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma, Archives of Surgery, vol.127, issue.4, pp.392-401, 1960.
DOI : 10.1001/archsurg.1992.01420040034005

J. Benson and G. Della-rovere, Management of the axilla in women with breast cancer, The Lancet Oncology, vol.8, issue.4, pp.331-379, 2007.
DOI : 10.1016/S1470-2045(07)70103-1

G. Lyman, A. Giuliano, M. Somerfield, A. Benson, D. Bodurka et al., American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer, Journal of Clinical Oncology, vol.23, issue.30, pp.7703-7723, 2005.
DOI : 10.1200/JCO.2005.08.001

D. Krag, S. Anderson, T. Julian, A. Brown, S. Harlow et al., Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, The Lancet Oncology, vol.11, issue.10, pp.927-960, 2010.
DOI : 10.1016/S1470-2045(10)70207-2

A. Giuliano, L. Mccall, P. Beitsch, P. Whitworth, M. Morrow et al., ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node., Journal of Clinical Oncology, vol.28, issue.18_suppl, p.506, 2010.
DOI : 10.1200/jco.2010.28.18_suppl.cra506

V. Galimberti, E. Botteri, C. Chifu, O. Gentilini, A. Luini et al., Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?, Breast Cancer Research and Treatment, vol.18, issue.3, pp.819-844, 2012.
DOI : 10.1093/annonc/mdm271

V. Galimberti, B. Cole, S. Zurrida, G. Viale, A. Luini et al., Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23???01): a phase 3 randomised controlled trial, The Lancet Oncology, vol.14, issue.4, pp.297-305, 2013.
DOI : 10.1016/S1470-2045(13)70035-4

C. Bonneau, D. Hequet, J. Estevez, N. Pouget, and R. Rouzier, Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes, European Journal of Surgical Oncology (EJSO), vol.41, issue.8, pp.998-1004, 2015.
DOI : 10.1016/j.ejso.2015.04.003

C. Louis-sylvestre, K. Clough, B. Asselain, J. Vilcoq, R. Salmon et al., Axillary Treatment in Conservative Management of Operable Breast Cancer: Dissection or Radiotherapy? Results of a Randomized Study With 15 Years of Follow-Up, Journal of Clinical Oncology, vol.22, issue.1, pp.97-101, 2004.
DOI : 10.1200/JCO.2004.12.108

F. Hoebers, J. Borger, A. Hart, J. Peterse, E. Th et al., Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes, Cancer, vol.50, issue.7, pp.1633-1675, 2000.
DOI : 10.1055/s-2008-1026346

K. Chu, R. Turner, N. Hansen, M. Brennan, A. Bilchik et al., Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg, avr, vol.229, issue.4, pp.536-577, 1999.
DOI : 10.1097/00000658-199904000-00013

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1191740/pdf

R. Hwang, S. Krishnamurthy, K. Hunt, N. Mirza, F. Ames et al., Clinicopathologic Factors Predicting Involvement of Nonsentinel Axillary Nodes in Women With Breast Cancer, Annals of Surgical Oncology, vol.354, issue.3, pp.248-54, 2003.
DOI : 10.1245/ASO.2003.05.020

C. Coutant, O. Morel, M. Antoine, S. Uzan, and E. Barranger, Ganglion sentinelle m??tastatique d???un cancer du sein : peut-on ??viter le curage axillaire compl??mentaire ?, Journal de Chirurgie, vol.144, issue.6, pp.492-501, 2007.
DOI : 10.1016/S0021-7697(07)79774-0

K. Van-zee, D. Manasseh, J. Bevilacqua, S. Boolbol, J. Fey et al., A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy, Annals of Surgical Oncology, vol.20, issue.10, pp.1140-51, 2003.
DOI : 10.1007/978-1-4757-3462-1

X. Bi, Y. Wang, M. Li, P. Chen, Z. Zhou et al., Validation of the Memorial Sloan Kettering Cancer Center nomogram for predicting non-sentinel lymph node metastasis in sentinel lymph node-positive breast-cancer patients. OncoTargets Ther, pp.487-93, 2015.

I. Rubio, M. Espinosa-bravo, R. M. , A. V. Diaz, M. Hardisson et al., Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients, Breast Cancer Research and Treatment, vol.18, issue.9, pp.371-80, 2014.
DOI : 10.1245/s10434-011-1593-7

H. Kohrt, R. Olshen, H. Bermas, W. Goodson, D. Wood et al., New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients, BMC Cancer, vol.91, issue.2, p.66, 2008.
DOI : 10.1007/s10549-004-5781-z

M. Liu, S. Wang, L. Pan, D. Yang, F. Xie et al., A New Model for Predicting Non-Sentinel Lymph Node Status in Chinese Sentinel Lymph Node Positive Breast Cancer Patients, PLoS ONE, vol.12, issue.8, p.104117, 2014.
DOI : 10.1371/journal.pone.0104117.t005

A. Chagpar, C. Scoggins, R. Martin, E. Cook, T. Mccurry et al., Predicting Patients at Low Probability of Requiring Postmastectomy Radiation Therapy, Annals of Surgical Oncology, vol.61, issue.2, pp.670-677, 2007.
DOI : 10.1016/j.ijrobp.2004.05.069

A. Katz, B. Smith, M. Golshan, A. Niemierko, W. Kobayashi et al., Nomogram for the Prediction of Having Four or More Involved Nodes for Sentinel Lymph Node???Positive Breast Cancer, Journal of Clinical Oncology, vol.26, issue.13, pp.2093-2101, 2008.
DOI : 10.1200/JCO.2007.11.9479

T. Meretoja, M. Leidenius, P. Heikkilä, G. Boross, I. Sejben et al., International Multicenter Tool to Predict the Risk of Nonsentinel Node Metastases in Breast Cancer, JNCI: Journal of the National Cancer Institute, vol.104, issue.24, pp.1888-96, 2012.
DOI : 10.1093/jnci/djs455

C. Coutant, C. Olivier, E. Lambaudie, E. Fondrinier, F. Marchal et al., Comparison of Models to Predict Nonsentinel Lymph Node Status in Breast Cancer Patients With Metastatic Sentinel Lymph Nodes: A Prospective Multicenter Study, Journal of Clinical Oncology, vol.27, issue.17, pp.2800-2808, 2009.
DOI : 10.1200/JCO.2008.19.7418

URL : https://hal.archives-ouvertes.fr/hal-00378786

C. Coutant, R. Rouzier, C. Olivier, C. Bezu, O. Marpeau et al., Mod??les pr??dictifs d???envahissement des ganglions non sentinelles en cas de m??tastases des ganglions sentinelles dans le cancer du sein, Gyn??cologie Obst??trique & Fertilit??, vol.37, issue.2, pp.160-166, 2009.
DOI : 10.1016/j.gyobfe.2008.09.021

G. Werkoff, E. Lambaudie, E. Fondrinier, J. Levêque, F. Marchal et al., Prospective Multicenter Comparison of Models to Predict Four or More Involved Axillary Lymph Nodes in Patients With Breast Cancer With One to Three Metastatic Sentinel Lymph Nodes, Journal of Clinical Oncology, vol.27, issue.34, pp.5707-5719, 2009.
DOI : 10.1200/JCO.2009.21.9139

URL : https://hal.archives-ouvertes.fr/hal-00428538

J. Hanley and B. Mcneil, The meaning and use of the area under a receiver operating characteristic (ROC) curve., Radiology, vol.143, issue.1, pp.29-36, 1982.
DOI : 10.1148/radiology.143.1.7063747

B. Fisher, M. Bauer, D. Wickerham, C. Redmond, E. Fisher et al., Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update, Cancer, vol.152, issue.9, pp.1551-1558, 1983.
DOI : 10.1093/ajcp/65.4.439

A. Giuliano, K. Hunt, K. Ballman, P. Beitsch, P. Whitworth et al., Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis, JAMA, vol.305, issue.6, pp.569-75, 2011.
DOI : 10.1001/jama.2011.90

URL : http://jama.jamanetwork.com/data/journals/jama/18279/joc15004_569_575.pdf

K. Albain, W. Barlow, S. Shak, G. Hortobagyi, R. Livingston et al., Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial, The Lancet Oncology, vol.11, issue.1, pp.55-65, 2010.
DOI : 10.1016/S1470-2045(09)70314-6

S. Mook, M. Schmidt, G. Viale, G. Pruneri, I. Eekhout et al., The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1???3 positive lymph nodes in an independent validation study, Breast Cancer Research and Treatment, vol.3, issue.2, pp.295-302, 2009.
DOI : 10.1093/jnci/94.2.116

URL : https://hal.archives-ouvertes.fr/hal-00478252

B. Wallden, J. Storhoff, T. Nielsen, N. Dowidar, C. Schaper et al., Development and verification of the PAM50-based Prosigna breast cancer gene signature assay, BMC Medical Genomics, vol.20, issue.5, p.54, 2015.
DOI : 10.1158/1078-0432.CCR-13-1845

F. Cardoso, . Van-'t, L. Veer, J. Bogaerts, L. Slaets et al., 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer, New England Journal of Medicine, vol.375, issue.8, pp.717-746, 2016.
DOI : 10.1056/NEJMoa1602253

URL : http://spiral.imperial.ac.uk/bitstream/10044/1/39633/7/nejmoa1602253.pdf

M. Pamilo, M. Soiva, and E. Lavast, Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients., Journal of Ultrasound in Medicine, vol.8, issue.3, pp.115-135, 1989.
DOI : 10.7863/jum.1989.8.3.115

S. Krishnamurthy, N. Sneige, D. Bedi, B. Edieken, B. Fornage et al., Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma, Cancer, vol.25, issue.5, pp.982-990, 2002.
DOI : 10.1002/cncr.10786

S. Alvarez, E. Añorbe, P. Alcorta, F. López, I. Alonso et al., Role of Sonography in the Diagnosis of Axillary Lymph Node Metastases in Breast Cancer: A Systematic Review, American Journal of Roentgenology, vol.186, issue.5, pp.1342-1350, 2006.
DOI : 10.2214/AJR.05.0936

A. Moorman, R. Bourez, D. De-leeuw, and E. Kouwenhoven, Pre-operative Ultrasonographic Evaluation of Axillary Lymph Nodes in Breast Cancer Patients: For Which Group Still of Additional Value and in Which Group Cause for Special Attention?, Ultrasound in Medicine & Biology, vol.41, issue.11, pp.2842-2850, 2015.
DOI : 10.1016/j.ultrasmedbio.2015.06.013

J. Gooch, T. King, A. Eaton, L. Dengel, M. Stempel et al., The Extent of Extracapsular Extension May Influence the Need for Axillary Lymph Node Dissection in Patients with T1???T2 Breast Cancer, Annals of Surgical Oncology, vol.139, issue.9, pp.2897-903, 2014.
DOI : 10.1007/s10549-013-2561-7